\
&
Contact us
\
&
Contact us
Published on | 1 year ago
Programmes Enhancing EU R&I Horizon EuropeThe Communication ‘Implementation of the European Research Area (ERA): Strengthening Europe’s Research and Innovation: The ERA’s Journey and Future Directions’ has been adopted on 22 October by the Commission.
The Communication takes stock and assesses the progress made since the previous Communication ‘A new ERA for Research and Innovation‘ (2020) in which the four key objectives are laid out:
and identifies remaining challenges which set the direction for future activities.
More information can be found in the European Commission press release, including a factsheet on the Communication and the videos ‘The #EUResearchArea over time: 2000 until today’ and ‘ERA testimonials’.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Research Infrastructures Horizon Europe Digital Europe
Building on the revised Charter for access to research infrastructures , this new Charter will be specifically aimed at facilitating access of companies. It will make it easier for companies, especially small and medium-sized businesses (SMEs), startups and scaleups, to access Europe’s world-class research and technology... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
